VOOZH about

URL: https://www.nature.com/articles/d41586-021-03672-3?error=cookies_not_supported&code=67a44857-3321-4a3b-9439-e8219caaa07f

⇱ Omicron likely to weaken COVID vaccine protection


Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The fast-spreading Omicron SARS-CoV-2 variant is highly likely to compromise some of the protection from vaccines, suggest the first laboratory studies of Omicron’s ability to evade immunity.

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

$32.99 / 30 days

cancel any time

Subscribe to this journal

Receive 52 print issues and online access

$199.00 per year

only $3.83 per issue

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 600, 367-368 (2021)

doi: https://doi.org/10.1038/d41586-021-03672-3

References

  1. Wilhelm, A. et al. Preprint at medRxiv https://doi.org/10.1101/2021.12.07.21267432 (2021).

Download references

Subjects

Latest on:

  • πŸ‘ Image

    Exclusive: NIH ousts infectious-disease leaders as COVID scientists face US charges

    News

  • πŸ‘ Image

    At last, a pill that can prevent COVID after exposure to infected people

    News

  • πŸ‘ Image

    Steric hindrance of antibody binding in an Omicron spike fusion intermediate

    Article

Jobs

πŸ‘ Nature Briefing

Sign up for the Nature Briefing newsletter β€” what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links